{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:16:07Z","timestamp":1792088167407,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.taap.2020.115246","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T22:47:50Z","timestamp":1600469270000},"page":"115246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"special_numbering":"C","title":["Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1\/2, p38\u03b1, and NF-\u03baB signaling"],"prefix":"10.1016","volume":"407","author":[{"given":"Rania","family":"Khalil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Shata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman M.","family":"Abd El-Kader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hossam","family":"Sharaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walied S.","family":"Abdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha A.","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2020.115246_bb0005","first-page":"1","article-title":"Blockade of PGE2, PGD2 receptors confers protection against Prepatent schistosomiasis Mansoni in mice","volume":"240","author":"Abdel-Ghany","year":"2015","journal-title":"J. Egypt. Soc. Parasitol."},{"key":"10.1016\/j.taap.2020.115246_bb0010","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1139\/cjpp-2017-0680","article-title":"Vildagliptin\/pioglitazone combination improved the overall glycemic control in type I diabetic rats","volume":"96","author":"Abdelhamid","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.taap.2020.115246_bb0015","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.fct.2018.07.027","article-title":"Hepatoprotective effects of diosmin and\/or sildenafil against cholestatic liver cirrhosis: the role of Keap-1\/Nrf-2 and P38-MAPK\/NF-\u03baB\/iNOS signaling pathway","volume":"120","author":"Ali","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.taap.2020.115246_bb0020","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.2337\/dc06-0703","article-title":"Effect of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy on glycemic control in patients with type 2 diabetes","volume":"29","author":"Aschner","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.taap.2020.115246_bb0025","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jep.2015.04.013","article-title":"Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-\u03b2\/Smad signaling in hepatocellular carcinoma by multi-target mechanism","volume":"169","author":"Boye","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2020.115246_bb0030","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.taap.2020.115246_bb0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s10557-014-6539-4","article-title":"DPP-4 inhibitors repress NLRP3 inflammasome and interleukin-1beta via GLP-1 receptor in macrophages through protein kinase C pathway","volume":"28","author":"Dai","year":"2014","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.taap.2020.115246_bb0040","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1001\/archinternmed.2010.188","article-title":"Sitagliptin-associated drug allergy: review of spontaneous adverse event reports","volume":"170","author":"Desai","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.taap.2020.115246_bb0045","doi-asserted-by":"crossref","first-page":"101732","DOI":"10.1016\/j.jddst.2020.101732","article-title":"Deferoxamine-loaded transfersomes accelerates healing of pressure ulcers in streptozotocin-induced diabetic rats","volume":"58","author":"El-Gizawy","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.taap.2020.115246_bb0050","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1124\/dmd.108.023010","article-title":"Absorption, metabolism, and excretion of [14C] vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans","volume":"37","author":"He","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.taap.2020.115246_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066520","article-title":"Soluble CD26\/dipeptidyl peptidase IV enhances the transcription of IL-6 and TNF-\u03b1 in THP-1 cells and monocytes","volume":"8","author":"Ikeda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.taap.2020.115246_bb0060","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.taap.2020.115246_bb0065","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00535-013-0783-4","article-title":"Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats","volume":"49","author":"Kaji","year":"2014","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.taap.2020.115246_bb0070","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000491763","article-title":"Effects of a DPP4 inhibitor on progression of NASH-related HCC and the p62\/Keap1\/Nrf2-pentose phosphate pathway in a mouse model","volume":"8","author":"Kawaguchi","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.taap.2020.115246_bb0075","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1463-1326.2010.01214.x","article-title":"An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of phase II and III clinical trials","volume":"12","author":"Ligueros-Saylan","year":"2010","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.taap.2020.115246_bb0080","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cytogfr.2013.06.002","article-title":"Smad phospho-isoforms direct context-dependent TGF-\u03b2 signaling","volume":"24","author":"Matsuzaki","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.taap.2020.115246_bb0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.taap.2020.115246_bb0090","doi-asserted-by":"crossref","first-page":"S39317","DOI":"10.4137\/JCM.S39317","article-title":"Linagliptin has wide-ranging anti-inflammatory points of action in human umbilical vein endothelial cells","volume":"7","author":"Nakamura","year":"2016","journal-title":"Jap. Clin. Med."},{"key":"10.1016\/j.taap.2020.115246_bb0095","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1463-1326.2006.00704.x","article-title":"Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial","volume":"9","author":"Nauck","year":"2007","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.taap.2020.115246_bb0100","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/08860220902835863","article-title":"Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kB pathways","volume":"31","author":"Ozbek","year":"2009","journal-title":"Ren. Fail."},{"key":"10.1016\/j.taap.2020.115246_bb0105","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1185\/030079908X260925","article-title":"Efficacy and safety of sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes","volume":"24","author":"Raz","year":"2008","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.taap.2020.115246_bb0110","first-page":"Cd006739","article-title":"Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus","author":"Richter","year":"2008","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.taap.2020.115246_bb0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s42269-018-0020-7","article-title":"Angiotensin II: a key mediator in the development of liver fibrosis and cancer","volume":"42","author":"Saber","year":"2018","journal-title":"Bull. Nat. Res. Centre"},{"key":"10.1016\/j.taap.2020.115246_bb0120","first-page":"121","article-title":"Losartan, an angiotensin-II type 1 receptor blocker, attenuates CCl4-induced liver fibrosis with a positive impact on survival in mice","volume":"5","author":"Saber","year":"2017","journal-title":"World J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.taap.2020.115246_bb0125","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.intimp.2018.09.021","article-title":"Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis","volume":"64","author":"Saber","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.taap.2020.115246_bb0130","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3889\/oamjms.2018.167","article-title":"Liver protective effects of renin-angiotensin system inhibition have no survival benefits in hepatocellular carcinoma induced by repetitive Administration of diethylnitrosamine in mice","volume":"6","author":"Saber","year":"2018","journal-title":"Open Access Macedonian J. Med. Sci."},{"key":"10.1016\/j.taap.2020.115246_bb0135","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.toxlet.2018.05.036","article-title":"Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B","volume":"295","author":"Saber","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.taap.2020.115246_bb0140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1139\/cjpp-2017-0728","article-title":"Renin-angiotensin system inhibition ameliorates CCl4-induced liver fibrosis in mice through the inactivation of nuclear transcription factor kappa B","volume":"96","author":"Saber","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.taap.2020.115246_bb0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.abb.2019.07.014","article-title":"Telmisartan ameliorates dextran sodium sulfate-induced colitis in rats by modulating NF-\u03baB signalling in the context of PPAR\u03b3 agonistic activity","volume":"671","author":"Saber","year":"2019","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.taap.2020.115246_bb0150","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.taap.2018.12.020","article-title":"Olmesartan ameliorates chemically-induced ulcerative colitis in rats via modulating NF\u03baB and Nrf-2\/HO-1 signaling crosstalk","volume":"364","author":"Saber","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2020.115246_bb0155","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1007\/s00210-019-01706-2","article-title":"Telmisartan attenuates N-nitrosodiethylamine-induced hepatocellular carcinoma in mice by modulating the NF-\u03baB-TAK1-ERK1\/2 axis in the context of PPAR\u03b3 agonistic activity","volume":"392","author":"Saber","year":"2019","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.taap.2020.115246_bb0160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00280-020-04033-z","article-title":"Novel complementary antitumour effects of celastrol and metformin by targeting I\u03baB\u03baB, apoptosis and NLRP3 inflammasome activation in diethylnitrosamine-induced murine hepatocarcinogenesis","volume":"85","author":"Saber","year":"2020","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.taap.2020.115246_bb0165","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fendo.2018.00649","article-title":"Future perspectives on GLP-1 receptor agonists and GLP-1\/glucagon receptor co-agonists in the treatment of NAFLD","volume":"9","author":"Seghieri","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.taap.2020.115246_bb0170","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biopha.2017.02.010","article-title":"Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats","volume":"89","author":"Sokar","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2020.115246_bb0175","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.atherosclerosis.2010.08.064","article-title":"DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes","volume":"213","author":"Ta","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.taap.2020.115246_bb0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13098-015-0087-3","article-title":"Efficacy and safety of vildagliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T2DM inadequately controlled with dual combination of insulin and traditional oral hypoglycemic agent","volume":"7","author":"Tang","year":"2015","journal-title":"Diabetol. Metab. Syndr."},{"key":"10.1016\/j.taap.2020.115246_bb0185","doi-asserted-by":"crossref","first-page":"116881","DOI":"10.1016\/j.lfs.2019.116881","article-title":"Salvianolic acid B exerts anti-liver fibrosis effects via inhibition of MAPK-mediated phospho-Smad2\/3 at linker regions in vivo and in vitro","volume":"239","author":"Wu","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2020.115246_bb0190","doi-asserted-by":"crossref","first-page":"19095","DOI":"10.1038\/s41598-019-55666-x","article-title":"Mebendazole augments sensitivity to sorafenib by targeting MAPK and BCL-2 signalling in n-nitrosodiethylamine-induced murine hepatocellular carcinoma","volume":"9","author":"Younis","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2020.115246_bb0195","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/jcm5040041","article-title":"Signal transduction pathways of EMT induced by TGF-\u03b2, SHH, and WNT and their crosstalks","volume":"5","author":"Zhang","year":"2016","journal-title":"J. Clin. Med."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20303720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X20303720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:51:52Z","timestamp":1758574312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X20303720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":39,"alternative-id":["S0041008X20303720"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2020.115246","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1\/2, p38\u03b1, and NF-\u03baB signaling","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2020.115246","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115246"}}